Glenmark Pharmaceuticals informs about press release
Date: 21-01-2016Glenmark Pharmaceuticals has informed about a Press Release dated January 21, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg’.
The above information is a part of company’s filings submitted to BSE.